| NTP ICE endocrine |
AC50 |
1.75364714262133 |
uM |
- |
- |
- |
ERPathway2016; ER Pathway Model, Antagonist |
sheet=Integrated_approaches; excel_row=1554; RecordID=ERPathway2016_167; DatasetName=ERPathway2016; DTXSID=DTXSID5041306; Assay=ER Pathway Model, Antagonist; Endpoint=AC50; Response=1.75364714262133; Response_Unit=uM; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5041306 |
| NTP ICE endocrine |
AC50 |
5.992535597 |
uM |
- |
- |
- |
ARPathway2016; AR Pathway Model, Agonist |
sheet=Integrated_approaches; excel_row=1548; RecordID=ARPathway2016_52; DatasetName=ARPathway2016; DTXSID=DTXSID5041306; Assay=AR Pathway Model, Agonist; Endpoint=AC50; Response=5.992535597; Response_Unit=uM; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5041306 |
| NTP ICE endocrine |
AC50/EC50/IC50 |
1323 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13285; Record_ID=endocrine_invitro_4117; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID5041306; Assay=AR Transactivation-Antagonist; Endpoint=AC50/EC50/IC50; Reported_Response=1323; Reported_Response_Unit=nM; Response=1323; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Molina-Molina et al. 2008; 18706922; 10.1016/j.taap.2008.07.017; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5041306 |
| NTP ICE endocrine |
AC50/EC50/IC50 |
1530 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13358; Record_ID=endocrine_invitro_4131; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID5041306; Assay=AR Transactivation-Antagonist; Endpoint=AC50/EC50/IC50; Reported_Response=1530; Reported_Response_Unit=nM; Response=1530; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Suzuki et al. 2005; 15694459; 10.1016/j.taap.2004.07.005; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5041306 |
| NTP ICE endocrine |
AC50/EC50/IC50 |
2500 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13128; Record_ID=endocrine_invitro_4073; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID5041306; Assay=AR Transactivation-Antagonist; Endpoint=AC50/EC50/IC50; Reported_Response=2500; Reported_Response_Unit=nM; Response=2500; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5041306 |
| NTP ICE endocrine |
AC50/EC50/IC50 |
4900 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13127; Record_ID=endocrine_invitro_4072; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID5041306; Assay=AR Transactivation-Antagonist; Endpoint=AC50/EC50/IC50; Reported_Response=4900; Reported_Response_Unit=nM; Response=4900; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Ermler et al. 2011; 21945941; 10.1016/j.taap.2011.09.005; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5041306 |
| NTP ICE endocrine |
AC50/EC50/IC50 |
62700 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Agonist |
sheet=Data_invitro; excel_row=7891; Record_ID=endocrine_invitro_3481; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID5041306; Assay=AR Transactivation-Agonist; Endpoint=AC50/EC50/IC50; Reported_Response=62700; Reported_Response_Unit=nM; Response=62700; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Kunz and Fent 2006; 16911836; 10.1016/j.aquatox.2006.06.016; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5041306 |
| NTP ICE endocrine |
ACC |
0.94227658039805 |
uM |
- |
- |
- |
ERPathway2016; ER Pathway Model, Antagonist |
sheet=Integrated_approaches; excel_row=1555; RecordID=ERPathway2016_167; DatasetName=ERPathway2016; DTXSID=DTXSID5041306; Assay=ER Pathway Model, Antagonist; Endpoint=ACC; Response=0.94227658039805; Response_Unit=uM; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5041306 |
| NTP ICE endocrine |
ACC |
10.53998791 |
uM |
- |
- |
- |
ARPathway2016; AR Pathway Model, Agonist |
sheet=Integrated_approaches; excel_row=1549; RecordID=ARPathway2016_52; DatasetName=ARPathway2016; DTXSID=DTXSID5041306; Assay=AR Pathway Model, Agonist; Endpoint=ACC; Response=10.53998791; Response_Unit=uM; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5041306 |
| NTP ICE endocrine |
LOEL |
200 |
mg/kg bw/day |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 19; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=777; Record_ID=endocrine_invivo_55; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5041306; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=200; Response_Unit=mg/kg/day; Species=Rat; Reported_Strain=Crj:CD(SD); Strain=Sprague-Dawley; Sex=Female; Route=Subcutaneous; Maximum_Dose=800; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Reference=Yamasaki et al. 2003; 12765246; 10.1016/s0378-4274(03)00019-5|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5041306 |
| NTP ICE endocrine |
LOEL |
229.8 |
mg/kg bw/day |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 20; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=784; Record_ID=endocrine_invivo_61; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5041306; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=229.8; Response_Unit=mg/kg/day; Species=Rat; Reported_Strain=Crj:CD(SD)IGS; Strain=Sprague-Dawley; Sex=Female; Route=Subcutaneous; Maximum_Dose=1000.0; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Reference=Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5041306 |
| NTP ICE endocrine |
LOEL |
300 |
mg/kg bw/day |
Mouse |
Subcutaneous |
Treatment_Duration=7 days; Age_at_First_Dose=PND 56; Age_Ovariectomized_or_Castrated=6 weeks; Time_Elapsed_Between_Surgery_and_Treatment=2 weeks; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=4 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=788; Record_ID=endocrine_invivo_63; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5041306; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=300; Response_Unit=mg/kg/day; Species=Mouse; Reported_Strain=C57BL/6J; Strain=C57BL/6; Sex=Female (ovariectomized); Route=Subcutaneous; Maximum_Dose=1000; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Reference=Ohta et al. 2012; 23037998; 10.2131/jts.37.879|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5041306 |
| NTP ICE endocrine |
LOEL |
1000 |
mg/kg bw/day |
Mouse |
Oral |
Treatment_Duration=7 days; Age_at_First_Dose=PND 56; Age_Ovariectomized_or_Castrated=6 weeks; Time_Elapsed_Between_Surgery_and_Treatment=2 weeks; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=4 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=779; Record_ID=endocrine_invivo_57; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5041306; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=1000; Response_Unit=mg/kg/day; Species=Mouse; Reported_Strain=C57BL/6J; Strain=C57BL/6; Sex=Female (ovariectomized); Route=Oral; Maximum_Dose=1000; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Reference=Ohta et al. 2012; 23037998; 10.2131/jts.37.879|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5041306 |
| NTP ICE endocrine |
Model Score |
0 |
unitless |
- |
- |
- |
ERPathway2016; ER Pathway Model, Antagonist |
sheet=Integrated_approaches; excel_row=1557; RecordID=ERPathway2016_167; DatasetName=ERPathway2016; DTXSID=DTXSID5041306; Assay=ER Pathway Model, Antagonist; Endpoint=Model Score; Response=0; Response_Unit=Unitless; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5041306 |
| NTP ICE endocrine |
Model Score |
0.00909 |
unitless |
- |
- |
- |
ARPathway2016; AR Pathway Model, Agonist |
sheet=Integrated_approaches; excel_row=1551; RecordID=ARPathway2016_52; DatasetName=ARPathway2016; DTXSID=DTXSID5041306; Assay=AR Pathway Model, Agonist; Endpoint=Model Score; Response=0.00909; Response_Unit=Unitless; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5041306 |
| NTP ICE endocrine |
Model Score |
0.397 |
unitless |
- |
- |
- |
ERPathway2016; ER Pathway Model, Agonist |
sheet=Integrated_approaches; excel_row=1556; RecordID=ERPathway2016_167; DatasetName=ERPathway2016; DTXSID=DTXSID5041306; Assay=ER Pathway Model, Agonist; Endpoint=Model Score; Response=0.397; Response_Unit=Unitless; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5041306 |
| NTP ICE endocrine |
Model Score |
0.448 |
unitless |
- |
- |
- |
ARPathway2016; AR Pathway Model, Antagonist |
sheet=Integrated_approaches; excel_row=1550; RecordID=ARPathway2016_52; DatasetName=ARPathway2016; DTXSID=DTXSID5041306; Assay=AR Pathway Model, Antagonist; Endpoint=Model Score; Response=0.448; Response_Unit=Unitless; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5041306 |
| NTP ICE endocrine |
NOEL |
400 |
mg/kg bw/day |
Rat |
Oral |
Treatment_Duration=10 days; Age_at_First_Dose=PND 56; Age_Ovariectomized_or_Castrated=PND 42; Time_Elapsed_Between_Surgery_and_Treatment=14 days; Time_Elapsed_Between_Last_Dose_and_Necropsy=18 to 36 hours; Number_of_Doses_Tested=6 |
In Vivo; Hershberger-Agonist |
sheet=Data_invivo; excel_row=2150; Record_ID=endocrine_invivo_923; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5041306; Assay=Hershberger-Agonist; Endpoint=NOEL; Response=400; Response_Unit=mg/kg/day; Species=Rat; Reported_Strain=Sprague-Dawley; Strain=Sprague-Dawley; Sex=Male (castrated); Route=Oral; Reference_Hormone=Testosterone propionate; Reference_Hormone_Dose=0.2; Reference_Hormone_Dose_Units=mg/kg/day; Reference_Hormone_Route=Subcutaneous; Additional_Information=Browne et al. 2018 unique record identifier 253; Reference=Yamasaki et al. 2003; 12504345; 10.1016/s0300-483x(02)00445-6|Browne et al. 2018; 30205136; 10.1016/j.reprotox.2018.08.016; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5041306 |
| NTP ICE endocrine |
Uterine weight increase vs control |
230 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 19; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=2239; Record_ID=endocrine_invivo_55; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5041306; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=230; Response_Unit=%; Species=Rat; Reported_Strain=Crj:CD(SD); Strain=Sprague-Dawley; Sex=Female; Route=Subcutaneous; Maximum_Dose=800.0; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Reference=Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5041306 |